Answer
Efavirenz is a non-nucleoside reverse transcriptase inhibitor that inhibits HIV-1 reverse transcriptase non-competitively, without significantly inhibiting HIV-2 reverse transcriptase or cellular DNA polymerases α, β, γ or δ.
Sources for this answer
- Efavirenz 600 mg film-coated tabletsAurobindo Pharma - Milpharm Ltd. · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked